DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response.
about
Epigenome-based personalized medicine in human cancerIntegrated analysis of high-resolution DNA methylation profiles, gene expression, germline genotypes and clinical end points in breast cancer patientsHigh-definition DNA methylation profiles from breast and ovarian carcinoma cell lines with differing doxorubicin resistanceFOXC1 overexpression is a marker of poor response to anthracycline-based adjuvant chemotherapy in sporadic triple-negative breast cancer.Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenolsQuantitative proteomic analysis reveals the perturbation of multiple cellular pathways in jurkat-T cells induced by doxorubicinThe effects of promoter methylation on downregulation of DAZAP2 in multiple myeloma cell lines.FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumorsGenome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence.Heterogeneous DNA Methylation Patterns in the GSTP1 Promoter Lead to Discordant Results between Assay Technologies and Impede Its Implementation as Epigenetic Biomarkers in Breast Cancer.Interindividual epigenetic variation in ABCB1 promoter and its relationship with ABCB1 expression and function in healthy Chinese subjectsCopy number aberrations of genes regulating normal thymus development in thymic epithelial tumors.DNA methylation in ductal carcinoma in situ of the breast.Aberrant promoter CpG methylation and its translational applications in breast cancer.Identification of Genetic and Epigenetic Variants Associated with Breast Cancer Prognosis by Integrative Bioinformatics Analysis.FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling.Promoter methylation patterns of ABCB1, ABCC1 and ABCG2 in human cancer cell lines, multidrug-resistant cell models and tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.Epigenetic activation of LY6K predicts the presence of metastasis and poor prognosis in breast carcinoma.The epigenetics of breast cancer.Epigenetic mechanisms in senescence, immortalisation and cancer.Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers.Epigenetic-dependent regulation of drug transport and metabolism: an update.Predictive biomarkers in breast cancer: their value in neoadjuvant chemotherapy.Epigenetic profiling joins personalized cancer medicine.DNA methylation, ageing and the influence of early life nutrition.Environmental challenge, epigenetic plasticity and the induction of altered phenotypes in mammals.Basal-like breast cancer defined by FOXC1 expression offers superior prognostic value: a retrospective immunohistochemical study.Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer.Genetic and genomic markers of anti-TNF treatment response in rheumatoid arthritis.Epigenetic alternations and cancer chemotherapy response.DNA Methylation of ADME Genes.The pharmacoepigenetics of drug metabolism and transport in breast cancer: review of the literature and in silico analysis.Pharmacoepigenetics: an element of personalized therapy?PTPN6 expression is epigenetically regulated and influences survival and response to chemotherapy in high-grade gliomas.FOXC1: an emerging marker and therapeutic target for cancer.BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers.Prognostic role of methylated GSTP1, p16, ESR1 and PITX2 in patients with breast cancer: A systematic meta-analysis under the guideline of PRISMA.BRCA2 carriers with male breast cancer show elevated tumour methylation.Effects of bisphenol A exposure on the proliferation and senescence of normal human mammary epithelial cells.
P2860
Q28083951-3B4AFC79-59C2-4CD5-AB98-90A81FD4EE44Q28305345-074C823B-BF2E-4DB6-B525-07E1F44268C4Q28474284-913DBFF2-84D8-446D-ACF9-CE6A23B86C8FQ33710341-3F0B5209-BDB3-4FB6-B997-DA1246A737A7Q33864180-102D484F-4C3F-4CE8-84E1-167F20B82937Q34283227-D1146194-6993-4681-A7B5-EF0A75C111F4Q34336372-20FDC7E8-1231-4647-9408-D5B68191E5C8Q34543873-57920858-D807-4912-9C5F-5D743ED0EEBCQ35008011-664C3D91-072A-4A31-B644-08890DFC5A71Q35841605-9E2EEC7F-1C69-4BB5-9281-21D8D7511474Q36096510-948A00F2-2652-4C7C-9B66-F926859FD050Q36243658-EDEE7264-4F1B-4FA5-9EEF-DC5332BABB79Q36778107-38A1F857-B7E4-487C-A7E8-A9A07460A425Q36998647-EFF08D14-3CDC-4196-8469-371B7D78704BQ37354053-F81C7228-D169-4D74-94CB-E008F74DEA11Q37577093-792C41C8-F812-4F6E-973E-7A188BAC256BQ37651856-DC69EBC9-3249-4D50-A430-F3F55A4E2381Q37687390-72F384AC-4593-4D6B-8189-C46D1E98E5BBQ37688300-F8DF5CBC-1988-4293-B646-F386F060FAB5Q37772356-5915D800-169A-4782-8838-E347AC5923B7Q37789778-04C8716B-51C0-4EDE-A9BF-4793DE8CCCB1Q37933098-169ACE61-41F8-43BA-AE2E-0199BA67CCC8Q38042440-5949FEC2-5372-4F31-986C-1062F15F3324Q38047337-DFB4E99A-CD5B-44CA-BAB2-DE466310E7C6Q38115623-24EBC4F0-4F42-4BF2-9E50-14FAD1EEA391Q38229830-D544D450-3D1D-49F1-B1B1-CF32C850308AQ38296752-E538B895-2EF6-4B0E-A2AC-2B90DD90B102Q38411253-DAFEB932-370E-49DC-9CE5-3777FA3CF907Q38503758-A64ADABB-D96A-44FF-B284-6ED479349F0FQ38529234-7F1EAD11-86ED-4334-85AA-5CFA1147D867Q38680431-EDE40E70-AAB7-48DB-82A6-A1F80B687297Q38802927-AF360A3C-53FD-4213-B22B-3A216C38DB99Q38937221-99342B7E-196F-4A29-B096-241A6D20ABE6Q39012550-839AD1BB-E603-4F4E-97B5-AB0D3FFC5199Q39025707-261AD0B2-97D2-4C3F-898E-B7670E361F16Q39176111-51AF0F9F-1329-45F3-AC56-AC1ED0325217Q39436579-5C7ECF57-3683-46EC-8EEF-374EF84D12FEQ41049866-3767404D-9B14-49C0-8308-25EB0E540ED3Q41274606-B99B8184-B073-47EE-9377-C3FCE7B8B9FEQ42722274-EA502059-5343-4EC0-A389-6116FAC90208
P2860
DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
DNA methylation profiling in d ...... rvival and treatment response.
@ast
DNA methylation profiling in d ...... rvival and treatment response.
@de
DNA methylation profiling in d ...... rvival and treatment response.
@en
type
label
DNA methylation profiling in d ...... rvival and treatment response.
@ast
DNA methylation profiling in d ...... rvival and treatment response.
@de
DNA methylation profiling in d ...... rvival and treatment response.
@en
prefLabel
DNA methylation profiling in d ...... rvival and treatment response.
@ast
DNA methylation profiling in d ...... rvival and treatment response.
@de
DNA methylation profiling in d ...... rvival and treatment response.
@en
P2093
P2860
P50
P356
P1433
P1476
DNA methylation profiling in d ...... rvival and treatment response.
@en
P2093
Emelyne Dejeux
Hiroko Solvang
Ida Bukholm
Jo Anders Rønneberg
P2860
P2888
P356
10.1186/1476-4598-9-68
P577
2010-03-25T00:00:00Z
P5875
P6179
1029777121